Get Premium to unlock powerful stock data

Top 5 1st Quarter Trades of ALETHEA CAPITAL MANAGEMENT, LLC

Author's Avatar
insider
May 13, 2022
Article's Main Image

ALETHEA CAPITAL MANAGEMENT, LLC recently filed their 13F report for the first quarter of 2022, which ended on 2022-03-31.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

8910 UNIVERSITY CENTER LN SAN DIEGO, CA 92122-1025

As of the latest 13F report, the guru’s equity portfolio contained 65 stocks valued at a total of $111,000,000. The top holdings were AXSM(39.06%), RNA(14.87%), and BIL(5.22%).

According to GuruFocus data, these were ALETHEA CAPITAL MANAGEMENT, LLC’s top five trades of the quarter.

Kura Oncology Inc


During the quarter, ALETHEA CAPITAL MANAGEMENT, LLC bought 271,820 shares of NAS:KURA for a total holding of 357,620. The trade had a 3.95% impact on the equity portfolio. During the quarter, the stock traded for an average price of $14.42.

On 05/13/2022, Kura Oncology Inc traded for a price of $11.62 per share and a market cap of $774,312,000. The stock has returned -56.73% over the past year.

GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 2 out of 10.

In terms of valuation, Kura Oncology Inc has a price-book ratio of 1.58 and a EV-to-Ebitda ratio of -2.12.

SPDR Bloomberg 1-3 Month T-Bill ETF


ALETHEA CAPITAL MANAGEMENT, LLC reduced their investment in ARCA:BIL by 36,168 shares. The trade had a 2.81% impact on the equity portfolio. During the quarter, the stock traded for an average price of $91.41.

On 05/13/2022, SPDR Bloomberg 1-3 Month T-Bill ETF traded for a price of $91.45 per share and a market cap of $17,072,801,000. The stock has returned -0.02% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

iShares 20 Year Treasury Bond ETF


ALETHEA CAPITAL MANAGEMENT, LLC reduced their investment in NAS:TLT by 21,782 shares. The trade had a 2.74% impact on the equity portfolio. During the quarter, the stock traded for an average price of $137.54.

On 05/13/2022, iShares 20+ Year Treasury Bond ETF traded for a price of $115.98 per share and a market cap of $18,000,096,000. The stock has returned -11.93% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

Axsome Therapeutics Inc


ALETHEA CAPITAL MANAGEMENT, LLC reduced their investment in NAS:AXSM by 80,770 shares. The trade had a 2.59% impact on the equity portfolio. During the quarter, the stock traded for an average price of $30.94.

On 05/13/2022, Axsome Therapeutics Inc traded for a price of $27.9 per share and a market cap of $1,085,687,000. The stock has returned -55.55% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 2 out of 10.

In terms of valuation, Axsome Therapeutics Inc has a price-book ratio of 69.79 and a EV-to-Ebitda ratio of -7.41.

Coterra Energy Inc


The guru established a new position worth 37,888 shares in NYSE:CTRA, giving the stock a 0.92% weight in the equity portfolio. Shares traded for an average price of $23.34 during the quarter.

On 05/13/2022, Coterra Energy Inc traded for a price of $29.78 per share and a market cap of $23,996,878,000. The stock has returned 77.94% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Coterra Energy Inc has a price-earnings ratio of 13.90, a price-book ratio of 2.07, a price-earnings-to-growth (PEG) ratio of 0.13, a EV-to-Ebitda ratio of 8.24 and a price-sales ratio of 4.45.

The price-to-GF Value ratio is 0.92, earning the stock a GF Value rank of 6.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.

Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles